Drug Type Small molecule drug |
Synonyms- |
Target |
Action degraders |
Mechanism BTK degraders(Tyrosine-protein kinase BTK degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Celiac Disease | Discovery | - | 07 Aug 2025 | |
| Hemic and Lymphatic Diseases | Discovery | - | 07 Aug 2025 | |
| Immune System Diseases | Discovery | - | 07 Aug 2025 | |
| Neoplasms | Discovery | - | 07 Aug 2025 | |
| Optic Neuritis | Discovery | - | 07 Aug 2025 | |
| Other Diseases | Discovery | - | 07 Aug 2025 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 07 Aug 2025 | |
| Urogenital Diseases | Discovery | - | 07 Aug 2025 |





